Home: Maucher Jenkins

Intellectual Property

Patents | Trade Marks | Designs

Supplementary Protection Certificates

SPCs can extend the length of patent protection in relation to particular pharmaceutical products, both human and veterinary, as well as plant protection.

A patent application would normally be filed at the initial stages of research and because medicinal products will undergo rigorous assessment and clinical trials before a marketing authorisation is finally granted, there is a risk that the patent expires before the pharmaceutical company has had time to make some return on its investment.


To compensate for the short effective life of a patent in this sector, most jurisdictions have provisions for supplementary protection certificates, which can extend the period of protection of a medicinal product for up to 5 years (or up to 5.5 years for paediatric medicinal products). This extension is a considerable asset, especially when relating to blockbuster drugs generating significant profits. 

Please contact our experts for more information:

Reuben Jacob, Dr. Fiona Kellas

Where would you like to go next?

To ensure we give you the best experience on our website we use Cookies. You can change your cookie settings at any time. However, if you continue without changing your settings we will presume you are happy to receive all cookies on the Maucher Jenkins website.